America’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots ...
Investor's Business Daily on MSN
Moderna plunges after FDA rejects its messenger-RNA-based flu shot
The FDA rejected Moderna's experimental flu vaccine Tuesday in a move that proved to be a blow to recently hot Moderna stock.
In a major blow to vaccine development, the FDA said it will not review Moderna’s application for the first mRNA-based flu shot.
The American pharmaceutical company Moderna announced that the United States Food and Drug Administration (FDA) has refused ...
The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has been known to scientists and the public. There has been some progress ...
Moderna advances messenger RNA platform technologies Therapeutics pipeline spans vaccines and disease targets nasdaq index ...
University of Oklahoma researchers have created a new drug delivery system that helps cancer cells take in much more of a ...
Messenger RNA (mRNA) is a subtype of RNA. An mRNA molecule carries a portion of the DNA code to other parts of the cell for processing. mRNA is created during transcription. During the transcription ...
The Food and Drug Administration rejected Moderna’s application for its mRNA-based flu vaccine, the drugmaker said Tuesday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results